We are live on ! Find out more
QCMA

Quad Capital Management Advisors Portfolio holdings

AUM $31.4M
1-Year Est. Return 22.55%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+22.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$211M
AUM Growth
+$123M
Cap. Flow
+$117M
Cap. Flow %
55.56%
Top 10 Hldgs %
81.25%
Holding
100
New
44
Increased
16
Reduced
4
Closed
34

Sector Composition

Rank Sector Weight
1 Healthcare 19.46%
2 Communication Services 18.6%
3 Technology 13.63%
4 Industrials 11.47%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$34.8M 16.49%
376,646
+245,485
+187% +$23.3M
RHT
2
DELISTED
Red Hat Inc
RHT
$33.3M 15.79%
177,569
+83,623
+89% +$15.4M
ZAYO
3
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$24.5M 11.6%
+744,405
New +$23.8M
FDC
4
DELISTED
First Data Corporation
FDC
$20.9M 9.9%
772,000
+745,000
+2,759% +$19.4M
LLL
5
DELISTED
L3 Technologies, Inc.
LLL
$16M 7.59%
+65,210
New +$15.2M
PVT
6
DELISTED
Pivotal Acquisition Corp.
PVT
$10.9M 5.17%
+1,075,000
New +$10.8M
CZR
7
DELISTED
Caesars Entertainment Corporation
CZR
$10.5M 4.95%
+885,000
New +$8.38M
APC
8
DELISTED
Anadarko Petroleum
APC
$9.82M 4.65%
+139,135
New +$9.33M
DATA
9
DELISTED
Tableau Software, Inc.
DATA
$6.68M 3.16%
+40,250
New +$5.29M
WBC
10
DELISTED
WABCO HOLDINGS INC.
WBC
$4.14M 1.96%
+31,205
New +$4.12M
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.23T
$2.87M 1.36%
52,940
+40,760
+335% +$2.36M
BLNE
12
Beeline Holdings
BLNE
$30.9M
$2.57M 1.22%
2,859
+1,230
+76% +$1.29M
MGLN
13
DELISTED
Magellan Health Services, Inc.
MGLN
$2.26M 1.07%
+30,404
New +$2.04M
IWM icon
14
iShares Russell 2000 ETF
IWM
$82.2B
$2.18M 1.03%
+14,000
New +$2.16M
KO icon
15
Coca-Cola
KO
$351B
$2.09M 0.99%
41,000
+22,540
+122% +$1.1M
ONCE
16
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.04M 0.97%
19,922
-77,038
-79% -$8.31M
DM
17
DELISTED
Desktop Metal, Inc.
DM
$1.95M 0.92%
+20,000
New +$1.94M
UBER icon
18
Uber
UBER
$147B
$1.82M 0.86%
+39,234
New +$1.67M
ARRY
19
DELISTED
Array Biopharma Inc
ARRY
$1.68M 0.8%
+36,250
New +$1.02M
FOXA icon
20
Fox Class A
FOXA
$24.2B
$1.29M 0.61%
+35,214
New +$1.29M
LHX icon
21
L3Harris
LHX
$52.5B
$1.28M 0.61%
+6,780
New +$1.22M
NFLX icon
22
Netflix
NFLX
$290B
$1.06M 0.5%
28,750
-10,470
-27% -$378K
SONY icon
23
Sony
SONY
$124B
$811K 0.38%
+77,390
New +$760K
BABA icon
24
Alibaba
BABA
$276B
$777K 0.37%
4,585
+2,644
+136% +$456K
CRWD icon
25
CrowdStrike
CRWD
$207B
$763K 0.36%
+44,708
New +$760K

Similar funds

Quad Capital Management Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Quad Capital Management Advisors held 100 positions worth $211M, up 141% from $87.8M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Quad Capital Management Advisors deployed $117M of net new capital in Q2 2019, opening 44 new positions and adding to 16 existing holdings. Its largest new stake was Zayo Group Holdings, Inc.: 744,405 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Spark Therapeutics, Inc. Common Stock, an estimated $8.31M trimmed.

  • Quad Capital Management Advisors's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 744,405 shares worth $24.5M.
  • Quad Capital Management Advisors added most to Celgene Corp in Q2 2019, an estimated $23.3M increase.
  • Quad Capital Management Advisors's biggest Q2 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $8.31M.
  • Quad Capital Management Advisors fully exited Coty in Q2 2019, selling an estimated $12.1M.
  • Quad Capital Management Advisors's ten largest holdings make up 81% of its $211M portfolio in Q2 2019.
  • Quad Capital Management Advisors opened 44 new positions and closed 34 in Q2 2019.
  • Quad Capital Management Advisors's portfolio value rose 141% quarter-over-quarter to $211M.

Based on Quad Capital Management Advisors's 13F filing for Q2 2019, filed 8 Aug 2019.